Journal
NEUROSURGICAL REVIEW
Volume 45, Issue 1, Pages 729-739Publisher
SPRINGER
DOI: 10.1007/s10143-021-01537-x
Keywords
Chronic subdural hematoma; Antithrombotics; Anticoagulants; Antiplatelets; Comorbidities; Reoperation; Risk factors
Categories
Funding
- Projekt DEAL
Ask authors/readers for more resources
In an aging Western society, the incidence of chronic subdural hematomas (cSDH) is increasing. A study on 623 patients treated for cSDH from 2006 to 2016 found that comorbidities, not antithrombotic drugs, were an independent predictor for the need for reoperations. Patients on anticoagulants and antiplatelets may have more comorbidities, but their clinical outcomes after surgical evacuation of cSDH are comparable to those without antithrombotics.
In an aging Western society, the incidence of chronic subdural hematomas (cSDH) is continuously increasing. In this study, we reviewed our clinical management of cSDH patients and identified predictive factors for the need of reoperation due to residual or recurrent hematomas with a focus on the use of antithrombotic drugs. In total, 623 patients who were treated for cSDH with surgical evacuation between 2006 and 2016 at our department were retrospectively analyzed. Clinical and radiological characteristics and laboratory parameters were investigated as possible predictors of reoperation with univariate and multivariate analyses. Additionally, clinical outcome measures were compared between patients on anticoagulants, on antiplatelets, and without antithrombotic medication. In univariate analyses, patients on anticoagulants and antiplatelets presented significantly more often with comorbidities, were significantly older, and their risk for perioperative complications was significantly increased. Nevertheless, their clinical outcome was comparable to that of patients without antithrombotics. In multivariate analysis, only the presence of comorbidities, but not antithrombotics, was an independent predictor for the need for reoperations. Patients on antithrombotics do not seem to necessarily have a significantly increased risk for residual hematomas or rebleeding requiring reoperation after cSDH evacuation. More precisely, the presence of predisposing comorbidities might be a key independent risk factor for reoperation. Importantly, the clinical outcomes after surgical evacuation of cSDH are comparable between patients on anticoagulants, antiplatelets, and without antithrombotics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available